loader image
Wednesday, November 19, 2025
90 F
McAllen
- Advertisement -

UT System special adviser Dr. Julio León provides update at UTPA on new university

Translate to Spanish or other 102 languages!

Pictured left to right during León's visit are UTPA Provost and Vice President for Academic Affairs Dr. Havidán Rodríguez; Dr. León; UTPA President Dr. Robert S. Nelsen; and UTB Provost and Vice President of Academic Affairs Dr. Alan F. J. Artibise.
Pictured left to right during León’s visit are UTPA Provost and Vice President for Academic Affairs Dr. Havidán Rodríguez; Dr. León; UTPA President Dr. Robert S. Nelsen; and UTB Provost and Vice President of Academic Affairs Dr. Alan F. J. Artibise.
 

An update on the new university formed by the merger of The University of Texas-Pan American and the University of Texas at Brownsville was held at UT Pan American Sept. 20 for staff and faculty and attended by administrators from both institutions.

- Advertisement -

Attendees heard from and met with Dr. Julio León, newly appointed special adviser to The University of Texas System’s Office of Academic Affairs, who will lead the transition process.

León, who previously served 25 years as president of Missouri Southern State University and has held a number of leadership positions in several national higher education organizations, will work from the Regional Academic Health Center in Harlingen as he leads and coordinates the nearly 50 inter-campus working groups composed of faculty, staff, students and community members that will assist the UT System administration with planning the new university and medical school.

Go to the Project South Texas website at www.projectsouthtexas.com to learn more about the new university’s guiding principles, timeline and latest news regarding the transition.

- Advertisement -

 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Paxton Secures $41.5M from Pfizer & Tris Pharma for Providing Adulterated Drugs to Children

Attorney General Ken Paxton has secured a $41.5 million settlement with Pfizer and Tris Pharma for allegedly providing adulterated pharmaceutical drugs to Texas children in violation of the Texas Health Care Program Fraud Prevention Act (“THFPA”).    

STHS’ South Texas Healthy Living Episode on Diabetes Awareness, Nov. 30th

The United States is experiencing a national health crisis as the incidence of diabetes continues to climb across the country.

DHR Health Encourages Early Detection with $99 Lung Cancer Screening Special Thru Dec. 31st

Lung cancer remains the leading cause of cancer death in the United States, accounting for about one in five cancer deaths nationwide. According to the American Cancer Society, an estimated 226,650 new cases of lung cancer will be diagnosed in 2025, and 124,730 people are expected to die from the disease. Each year, lung cancer claims more lives than colon, breast, and prostate cancers combined.

Aesculap Implant Systems Settles for $38.5M, Enters Non-Prosecution Deal

Medical device company Aesculap Implant Systems LLC (Aesculap), based in Center Valley, Pennsylvania, has agreed to pay $38.5 million to resolve allegations under the False Claims Act that the company sold knee replacement devices that it knew would fail prematurely at a higher than acceptable rate, resulting in false claims to Medicare and Medicaid.
- Advertisement -
×